Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data.

ABSTRACT:

Objectives

Hidradenitis suppurativa (HS) causes substantial morbidity and quality-of-life impairment. We examined demographic/clinical characteristics of patients with HS and treatment patterns, prevalence and healthcare resource utilisation/expenditures related to HS in the real-world.

Design

Retrospective claims data of MarketScan Commercial, Medicare Supplemental and Medicaid databases (2009-2014).

Setting

USA.

Participants

Patients aged ≥12 years with ≥3 non-diagnostic outpatient or inpatient claims with an HS diagnosis code and ≥12 months continuous enrolment with medical and pharmacy benefits before (preindex) and after (postindex) the earliest diagnosis of HS (index) were included.

Results

There were 11 325 Commercial/Medicare patients (mean age 3

SUBMITTER: Marvel J 

PROVIDER: S-EPMC6797383 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature